NCT03353064 (ETOUCH) is a NA clinical trial of Vivify in Hypercapnic Respiratory Failure, sponsored by Albert Einstein Healthcare Network.

Who is sponsoring NCT03353064?

NCT03353064 is sponsored by Albert Einstein Healthcare Network.

What drugs are being tested in NCT03353064?

Interventions in NCT03353064: Vivify, EMS.

What condition does NCT03353064 study?

NCT03353064 studies Hypercapnic Respiratory Failure, Chronic Obstructive Pulmonary Disease, Obesity Hypoventilation Syndrome, Sleep Disordered Breathing, Neuromuscular Diseases.

Is NCT03353064 still recruiting?

NCT03353064 is currently terminated. Last updated 29 October 2018.

Last reviewed 2018-10-29 · How we verify

NCT03353064: ETOUCH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory Failure

Terminated NA Last updated 29 October 2018

What this trial tests

NA trial testing Vivify in Hypercapnic Respiratory Failure in 4 participants. Terminated before completion.

Timeline

18 October 2017

Primary endpoint
26 October 2018

26 October 2018

Quick facts

Lead sponsor	Albert Einstein Healthcare Network
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	4
Start date	18 October 2017
Primary completion	26 October 2018
Estimated completion	26 October 2018
Sites	1 location across United States

Drugs / interventions tested

Vivify
EMS

Conditions studied

Hypercapnic Respiratory Failure — all drugs for Hypercapnic Respiratory Failure →
Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →
Obesity Hypoventilation Syndrome — all drugs for Obesity Hypoventilation Syndrome →
Sleep Disordered Breathing — all drugs for Sleep Disordered Breathing →

Sponsor

Albert Einstein Healthcare Network

Who can join

18 and older, any sex, with Hypercapnic Respiratory Failure or Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Hypercapnia Telemedicine Outreach Program (E-TOUCH Study) aims to utilize telemedicine technology, as well as emergency medical services (EMS) home visits to address the problem with poor follow-up and compliance among Einstein's hypercapnic patients. The hypothesis is that reaching out to the subjects' homes will allow more consistent healthcare delivery, increase healthcare efficiency and compliance with therapy, and overall decrease acute decompensated states / hypercapnic respiratory failure, decreasing ED visits and hospitalization.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).
Janjua S, Carter D, Threapleton CJ, Prigmore S, et al · · 2021 · cited 70× · PMID 34693988 · DOI 10.1002/14651858.cd013196.pub2

Verify or expand the search:

Other recruiting trials for Hypercapnic Respiratory Failure

Currently open trials in the same condition.

NCT06367686 — Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor · recruiting
NCT06047405 — NIV for Hypercapnic Respiratory Failure: AVAPS vs S/T BIPAP · NA · recruiting

Other Albert Einstein Healthcare Network trials

Trials by the same sponsor.

NCT07044323 — Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment · NA · recruiting
NCT06247904 — NIBS Therapy in Subacute Spinal Cord Injury · NA · enrolling by invitation
NCT06028334 — GetUp&Go: A Randomized Controlled Trial of an Intervention to Enhance Physical Activity After TBI · NA · recruiting
NCT04610346 — Assessing an Animal-Assisted Treatment Program for Adults With Aphasia: The Persons With Aphasia Training Dogs Program · NA · completed
NCT05687994 — Speech Entrainment Treatment for People With Aphasia · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03353064 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Albert Einstein Healthcare Network
Last refreshed: 29 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03353064.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing